Amgen bought Ch...
login
Shares
Bonds
π₯Pre-IPO
Dividends
Portfolio
More
ETF
Sectors
News
Calendar
Try for free
Login
×
Email
Password
Forgot your password?
Login
Resend my activation email
Need an account? Sign up.
Home
News
ChemoCentryx
Amgen bought ChemoCentryx
10/20/22 at 16:16
Share at
Vladimir Petenev
News editor
press@blackterminal.com
Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.
ChemoCentryx
Review
Source:
investors.amgen.com
Vladimir Petenev
News editor
Share at:
Share this news
×
To leave a comment, you must be logged in
Write your comment first
News feed
Teladoc Health reports on 3 months of 2023
4/27/23
TDOC
The Bank of America announced a quarterly dividend
4/26/23
BAC
The eBay announced a quarterly dividend
4/26/23
EBAY
The Pfizer announced a quarterly dividend
4/26/23
PFE
ZIL reported for 3 months of 2023 according to RAS
4/26/23
ZILL
SFI reported for 3 months of 2023 by RAS
4/26/23
SFIN
LSR reported for 3 months of 2023 according to RAS
4/26/23
LSRG
Activision Blizzard reported 3 months of 2023
4/26/23
ATVI
Abrau-Durso enters the energy drinks market
4/26/23
ABRD
Unipro will be managed by the head of Rosneft's Energy Department
4/26/23
UPRO
«
Previous
639
640
641
642
643
644
645
646
647
648
»
Next
BlackTerminal.com 2016 - 2025.
English (US)
English (US)
Π ΡΡΡΠΊΠΈΠΉ (Π Π€)